Xianming Wang

Learn More
BACKGROUND The aim of the study was to evaluate the clinical efficacy of superselective intra-arterial targeted neo-adjuvant chemotherapy in the treatment of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and human epidermal growth factor receptor 2 (HER2)-negative (triple-negative) breast cancer. PATIENTS AND METHODS.: A total of 47(More)
The expression and functions of microRNA (miR)-411 have been investigated in several types of cancer. However, until now, miR-411 in human breast cancer has not been examined. The present study investigated the expression, biological functions and molecular mechanisms of miR‑411 in human breast cancer, discussing whether it offers potential as a therapeutic(More)
BACKGROUND Estimating quality of life (QoL) in patients with breast cancer is of importance in assessing treatment outcomes. Adjuvant endocrine therapy is widely used for hormone receptor-positive (HR+) early-stage breast cancer (EBC), and evidence suggests that aromatase inhibitors (AIs) may improve QoL for these patients. This study evaluated QoL in(More)
In this study, we examine the potential of heart rate variability (HRV) as an efficient tool for predicting the onset of epilepsy in children. We totally collected 53 seizures EEG and ECG data using Video - EEG - ECG monitoring system. We then separated the ECG data into three segments: ten-minute before onset of each seizure, five-minute before onset of(More)
The aim of the present study was to observe the efficacy of neoadjuvant trastuzumab combined with docetaxel and carboplatin (TCH), and docetaxel, epirubicin and cyclo-phosphamide (TEC) chemotherapy in human epidermal growth factor receptor‑2 (HER-2)-overexpressing breast cancer. The total cohort of 64 cases of HER‑2‑overexpressing breast cancer patients was(More)
The breast cancer resistance protein (BCRP) is a recently characterized xenobiotic half‑transporter protein that acts as an energy‑dependent efflux pump and may be associated with the multidrug‑resistant phenotype. The aim of this study was to determine the association between BCRP expression and 5‑fluorouracil (5‑FU) resistance in clinical breast cancer(More)
  • 1